Skip to content

Clinical trials

Phase 3 Arthritis, Rheumatoid trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 3 Country / region: China Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20054
20062
20071
20081
20093
20101
20121
20131
20143
20162
20174
20186
20192
20202
20221
20234
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status5
Active, not recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche9
AbbVie3
Eli Lilly and Company3
GlaxoSmithKline3
Hangzhou Highlightll Pharmaceutical Co., Ltd2
Pfizer2
Astellas Pharma China, Inc.1
Beijing VDJBio Co., LTD.1
Bio-Thera Solutions1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid42
Arthritis4
Osteoarthritis2
Connective Tissue Diseases1
Dyspepsia1
Emergence Delirium1
Fibrosis1
Joint Diseases1
Lung Diseases, Interstitial1
Lymphoma, Follicular1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.